[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceutical & Biotechnology Environmental Monitoring-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

June 2019 | 156 pages | ID: PF17E45358BEN
MIReports Co., Limited

US$ 3,680.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Pharmaceutical & Biotechnology Environmental Monitoring-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical & Biotechnology Environmental Monitoring industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Pharmaceutical & Biotechnology Environmental Monitoring 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical & Biotechnology Environmental Monitoring worldwide and market share by regions, with company and product introduction, position in the Pharmaceutical & Biotechnology Environmental Monitoring market
Market status and development trend of Pharmaceutical & Biotechnology Environmental Monitoring by types and applications
Cost and profit status of Pharmaceutical & Biotechnology Environmental Monitoring, and marketing status
Market growth drivers and challenges

The report segments the global Pharmaceutical & Biotechnology Environmental Monitoring market as:

Global Pharmaceutical & Biotechnology Environmental Monitoring Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global Pharmaceutical & Biotechnology Environmental Monitoring Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Monitoring Equipment
Media
Software
Microbiology Services

Global Pharmaceutical & Biotechnology Environmental Monitoring Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Pharmaceutical Industry
Biotechnology Industry
Academic & Research Institutes

Global Pharmaceutical & Biotechnology Environmental Monitoring Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical & Biotechnology Environmental Monitoring Sales Volume, Revenue, Price and Gross Margin):
Danaher Corporation
Thermo Fisher Scientific
Merck KGaA
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
RMONI
Amphenol Advanced Sensors
Vaisala

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACEUTICAL & BIOTECHNOLOGY ENVIRONMENTAL MONITORING

1.1 Definition of Pharmaceutical & Biotechnology Environmental Monitoring in This Report
1.2 Commercial Types of Pharmaceutical & Biotechnology Environmental Monitoring
  1.2.1 Monitoring Equipment
  1.2.2 Media
  1.2.3 Software
  1.2.4 Microbiology Services
1.3 Downstream Application of Pharmaceutical & Biotechnology Environmental Monitoring
  1.3.1 Pharmaceutical Industry
  1.3.2 Biotechnology Industry
  1.3.3 Academic & Research Institutes
1.4 Development History of Pharmaceutical & Biotechnology Environmental Monitoring
1.5 Market Status and Trend of Pharmaceutical & Biotechnology Environmental Monitoring 2013-2023
  1.5.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Market Status and Trend 2013-2023
  1.5.2 Regional Pharmaceutical & Biotechnology Environmental Monitoring Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Pharmaceutical & Biotechnology Environmental Monitoring 2013-2017
2.2 Sales Market of Pharmaceutical & Biotechnology Environmental Monitoring by Regions
  2.2.1 Sales Volume of Pharmaceutical & Biotechnology Environmental Monitoring by Regions
  2.2.2 Sales Value of Pharmaceutical & Biotechnology Environmental Monitoring by Regions
2.3 Production Market of Pharmaceutical & Biotechnology Environmental Monitoring by Regions
2.4 Global Market Forecast of Pharmaceutical & Biotechnology Environmental Monitoring 2018-2023
  2.4.1 Global Market Forecast of Pharmaceutical & Biotechnology Environmental Monitoring 2018-2023
  2.4.2 Market Forecast of Pharmaceutical & Biotechnology Environmental Monitoring by Regions 2018-2023

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of Pharmaceutical & Biotechnology Environmental Monitoring by Types
3.2 Sales Value of Pharmaceutical & Biotechnology Environmental Monitoring by Types
3.3 Market Forecast of Pharmaceutical & Biotechnology Environmental Monitoring by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of Pharmaceutical & Biotechnology Environmental Monitoring by Downstream Industry
4.2 Global Market Forecast of Pharmaceutical & Biotechnology Environmental Monitoring by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Countries
  5.1.1 North America Pharmaceutical & Biotechnology Environmental Monitoring Sales by Countries (2013-2017)
  5.1.2 North America Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Countries (2013-2017)
  5.1.3 United States Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  5.1.4 Canada Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  5.1.5 Mexico Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
5.2 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Manufacturers
5.3 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Type (2013-2017)
  5.3.1 North America Pharmaceutical & Biotechnology Environmental Monitoring Sales by Type (2013-2017)
  5.3.2 North America Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Type (2013-2017)
5.4 North America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Downstream Industry (2013-2017)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Countries
  6.1.1 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales by Countries (2013-2017)
  6.1.2 Europe Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Countries (2013-2017)
  6.1.3 Germany Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  6.1.4 UK Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  6.1.5 France Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  6.1.6 Italy Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  6.1.7 Russia Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  6.1.8 Spain Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  6.1.9 Benelux Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
6.2 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Manufacturers
6.3 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Type (2013-2017)
  6.3.1 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales by Type (2013-2017)
  6.3.2 Europe Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Type (2013-2017)
6.4 Europe Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Downstream Industry (2013-2017)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Countries
  7.1.1 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales by Countries (2013-2017)
  7.1.2 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Countries (2013-2017)
  7.1.3 China Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  7.1.4 Japan Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  7.1.5 India Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  7.1.6 Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  7.1.7 Australia Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
7.2 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Manufacturers
7.3 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Type (2013-2017)
  7.3.1 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales by Type (2013-2017)
  7.3.2 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Type (2013-2017)
7.4 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Downstream Industry (2013-2017)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Countries
  8.1.1 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Sales by Countries (2013-2017)
  8.1.2 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Countries (2013-2017)
  8.1.3 Brazil Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  8.1.4 Argentina Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  8.1.5 Colombia Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
8.2 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Manufacturers
8.3 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Type (2013-2017)
  8.3.1 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Sales by Type (2013-2017)
  8.3.2 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Type (2013-2017)
8.4 Latin America Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Downstream Industry (2013-2017)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Countries
  9.1.1 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales by Countries (2013-2017)
  9.1.2 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Countries (2013-2017)
  9.1.3 Middle East Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
  9.1.4 Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Status (2013-2017)
9.2 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Manufacturers
9.3 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Type (2013-2017)
  9.3.1 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales by Type (2013-2017)
  9.3.2 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Type (2013-2017)
9.4 Middle East and Africa Pharmaceutical & Biotechnology Environmental Monitoring Market Status by Downstream Industry (2013-2017)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY ENVIRONMENTAL MONITORING

10.1 Global Economy Situation and Trend Overview
10.2 Pharmaceutical & Biotechnology Environmental Monitoring Downstream Industry Situation and Trend Overview

CHAPTER 11 PHARMACEUTICAL & BIOTECHNOLOGY ENVIRONMENTAL MONITORING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of Pharmaceutical & Biotechnology Environmental Monitoring by Major Manufacturers
11.2 Production Value of Pharmaceutical & Biotechnology Environmental Monitoring by Major Manufacturers
11.3 Basic Information of Pharmaceutical & Biotechnology Environmental Monitoring by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of Pharmaceutical & Biotechnology Environmental Monitoring Major Manufacturer
  11.3.2 Employees and Revenue Level of Pharmaceutical & Biotechnology Environmental Monitoring Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 PHARMACEUTICAL & BIOTECHNOLOGY ENVIRONMENTAL MONITORING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 Danaher Corporation
  12.1.1 Company profile
  12.1.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.1.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Danaher Corporation
12.2 Thermo Fisher Scientific
  12.2.1 Company profile
  12.2.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.2.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
12.3 Merck KGaA
  12.3.1 Company profile
  12.3.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.3.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Merck KGaA
12.4 Eurofins Sinensis
  12.4.1 Company profile
  12.4.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.4.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Eurofins Sinensis
12.5 Lonza
  12.5.1 Company profile
  12.5.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.5.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Lonza
12.6 Biomerieux
  12.6.1 Company profile
  12.6.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.6.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Biomerieux
12.7 VAI
  12.7.1 Company profile
  12.7.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.7.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of VAI
12.8 Cosasco
  12.8.1 Company profile
  12.8.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.8.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Cosasco
12.9 RMONI
  12.9.1 Company profile
  12.9.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.9.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of RMONI
12.10 Amphenol Advanced Sensors
  12.10.1 Company profile
  12.10.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.10.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Amphenol Advanced Sensors
12.11 Vaisala
  12.11.1 Company profile
  12.11.2 Representative Pharmaceutical & Biotechnology Environmental Monitoring Product
  12.11.3 Pharmaceutical & Biotechnology Environmental Monitoring Sales, Revenue, Price and Gross Margin of Vaisala

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY ENVIRONMENTAL MONITORING

13.1 Industry Chain of Pharmaceutical & Biotechnology Environmental Monitoring
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY ENVIRONMENTAL MONITORING

14.1 Cost Structure Analysis of Pharmaceutical & Biotechnology Environmental Monitoring
14.2 Raw Materials Cost Analysis of Pharmaceutical & Biotechnology Environmental Monitoring
14.3 Labor Cost Analysis of Pharmaceutical & Biotechnology Environmental Monitoring
14.4 Manufacturing Expenses Analysis of Pharmaceutical & Biotechnology Environmental Monitoring

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications